Concepedia

Maurie Markman

MM

191

Publications

21K

Citations

65

H-Index

1982

Active since

Affiliations

Cleveland Clinic(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

University of Arizona

Gynecologic Oncology Group

Maurie Markman is an author at Cleveland Clinic specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1982–2022

191

Publications

191

Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature

Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al. · Case Reports in Oncology · 2015 · 5.3K citations · Full text

Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

Maurie Markman, Brian N. Bundy, David S. Alberts et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

Maurie Markman, Robert Rothman, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1991 · 851 citations

, , +12

Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

William E. Winter, G. Larry Maxwell, Chunqiao Tian et al. · Journal of Clinical Oncology · 2007 · 839 citations · Full text

Ovarian cancer

Bryan T. Hennessy, Robert L. Coleman, Maurie Markman · The Lancet · 2009 · 644 citations

Rows per page

1–5 of 191